Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet?

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

(2016) Veeral Ajmera et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy

(2015) Vincent Wai-Sun Wong et al.   JOURNAL OF HEPATOLOGY

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2013) An Verrijken et al.   HEPATOLOGY

NAFLD in Asia—as common and important as in the West

(2013) Geoffrey C. Farrell et al.   Nature Reviews Gastroenterology & Hepatology

Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes

(2012) Sebastian Seidler et al.   BMC GASTROENTEROLOGY

Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis

(2011) Henning W. Zimmermann et al.   PLoS One